Sign inJoin waitlistJoin the waitlist

Zev A. Wainberg

Co-Director of the UCLA GI Oncology Program · UCLA

Credentials: · · ·

History

UCLA GI Oncology Program
Present
UCLA
Present

UCLA School of Medicine: Hematology-Oncology
Until 2006
Sackler School of Medicine
2003
Montefiore Medical Center Moses Division Hospital
Until 2003
Montefiore Medical Center Moses Division Hospital
Until 2001

Research

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial
JAMA Oncology · 2018 · 1,507 citations
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3…
JAMA Oncology · 2020 · 973 citations
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer
Journal of Clinical Oncology · 2018 · 704 citations

Randolph Hecht
18 papers
EO
Eileen O'Reilly
15 papers
JB
Johanna Bendell
15 papers
TD
Timothy Donahue
12 papers
DC
Daniel Catenacci
11 papers
YJ
Yelena Janjigian
11 papers
Peter Enzinger
10 papers
Shubham Pant
10 papers
Tanios Bekaii-Saab
10 papers
Joe Hines
9 papers
JC
Joseph Chao
9 papers
Manish Shah
9 papers

Grants

Causes and Consequences of Adenosine Signaling in Pancreatic Cancer
National Cancer Institute · R01
PI · $2M · University of California Los Angeles
2024–2029
Targeting KRAS and Adenosine Mediated Immunosuppression in Pancreatic Cancer
National Cancer Institute · R01
PI · $3M · University of California Los Angeles
2021–2026

Clinical trials

Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Principal investigator · Recruiting · Phase 1, Phase 2
Jonsson Comprehensive Cancer Center
2023–2027
Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer
Principal investigator · Completed · Early phase 1
Jonsson Comprehensive Cancer Center
2019–2024
PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Principal investigator · Completed · Phase 1
Jonsson Comprehensive Cancer Center
2014–2019
Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
Principal investigator · Completed · Phase 2
Translational Oncology Research International
2009–2014